Daewoong Co., Ltd. (KRX:003090)

Market Cap	864.84B
Revenue (ttm)	1.88T
Net Income (ttm)	123.36B
Shares Out	40.89M
EPS (ttm)	3,024.94
PE Ratio	6.99
Forward PE	7.15
Dividend	100.00 (0.47%)
Ex-Dividend Date	Dec 27, 2024

Volume	27,270
Average Volume	38,389
Open	21,000
Previous Close	20,950
Day's Range	21,000 - 21,350
52-Week Range	15,050 - 28,100
Beta	1.24
RSI	50.36
Earnings Date	Mar 7, 2025

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam, South...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 356
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003090

Financial Performance

In 2023, Daewoong's revenue was 1.81 trillion, an increase of 6.86% compared to the previous year's 1.70 trillion. Earnings were 152.67 billion, an increase of 48.85%.